Paola Perego

Fondazione IRCCS Istituto Nazionale dei Tumori

H指数:50

被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bioderived carbon nanodots from sulfonated lignin and spent coffee grounds: green nanoengineering of surface and interfacial redox properties

磺化木质素和废弃咖啡渣制备的生物衍生碳量子点：表面和界面氧化还原性质的绿色纳米工程

Surfaces and Interfaces

IF6.3

2026-11-110

PRE

Glycoglycerolipid-coated F/ZnO quantum dots: a biocompatible amphiphilic formulation for fluorescent nanoprobes

甘油糖脂包被的F/ZnO量子点：一种用于荧光纳米探针的生物相容性两亲性制剂

Colloids and Surfaces B: Biointerfaces

IF5.6

2026-04-020

PRE

Exploring Guanidinium Group Involvement in Hordatine Interactions with the G-Quadruplex Motif Within the c-MYC Promoter Region

探究胍基铵基团在合欢素与c-MYC启动子区域内G-四链体基序相互作用中的作用

International Journal of Molecular Sciences

IF4.9

2026-03-030

OAAI

Novel insights into taxane pharmacology: An update on drug resistance mechanisms, immunomodulation and drug delivery strategies

紫杉烷药理学的新见解：药物耐药机制、免疫调节和药物递送策略的最新进展

DRUG RESISTANCE UPDATES

IF21.7

2025-07-010

OAAI

Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery

Stem Cell Research & Therapy

IF7.3

2025-06-150

OAAI

Therapeutic Strategies to Improve the Treatment of Pleural Mesothelioma

改善胸膜间皮瘤治疗的治疗策略

CURRENT MEDICINAL CHEMISTRY

IF3.5

2024-04-162

PRE

CRISPR/Cas9 screening identifies the proteasome subunit PSMC6 as key for the survival of cisplatin-resistant ovarian carcinoma cells

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells

FRONTIERS IN ONCOLOGY

IF3.3

2023-09-181

OAAI

Increased serum levels of KiSS1-derived peptides in non-small cell lung cancer patient liquid biopsies and biological relevance

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2022-07-015

OAAI

P301L tau mutation leads to alterations of cell cycle, DNA damage response and apoptosis: Evidence for a role of tau in cancer

BIOCHEMICAL PHARMACOLOGY

IF5.6

2022-06-018

PRE

The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets

mTOR/4E-BP1/eIF4E信号通路作为癌症药物靶标的来源

CURRENT MEDICINAL CHEMISTRY

IF3.5

2022-06-0124

PRE

Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds

CURRENT MEDICINAL CHEMISTRY

IF3.5

2022-05-015

PRE

Synthesis and Investigation of the G-Quadruplex Binding Properties of Kynurenic Acid Derivatives with a Dihydroimidazoquinoline-3,5-dione Core

MOLECULES

IF4.6

2022-04-272

OAAI

Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells

BIOCHEMICAL PHARMACOLOGY

IF5.6

2022-03-0110

PRE

Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines

Perampanel和替莫唑胺在人脑胶质瘤细胞系中的协同作用

JOURNAL OF PERSONALIZED MEDICINE

IF3

2021-05-1031

OAAI

A trifunctional self-immolative spacer enables drug release with two non-sequential enzymatic cleavages

CHEMICAL COMMUNICATIONS

IF4.2

2021-01-019

The rediscovery of platinum-based cancer therapy

铂类癌症治疗的再发现

NATURE REVIEWS CANCER

IF66.8

2020-10-30565

PREAI

Extracellular lipid starvation modulates the effects of BRAF inhibitors in melanoma

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Fast Cyclization of a Proline‐Derived Self‐Immolative Spacer Improves the Efficacy of Carbamate Prodrugs

Angewandte Chemie-International Edition

IF16.9

2020-01-220

OAAI

Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer

EGFR突变的非小细胞肺癌对奥希替尼的耐药机制

BRITISH JOURNAL OF CANCER

IF6.8

2019-09-30898

OAAI

Paola Perego

个人简介

教育背景

工作经历

荣誉奖项

研究方向